Table 1

Demographic inputs for T2DM, NAFL, and NASH in the U.S. in 2017

Age-group (years)U.S. population sizeDiagnosed T2DMDiagnosed T2DM cohortNAFL prevalence in T2DMPrevalent NAFL cohortAnnual incidence rate of NASH in T2DM with NAFLNASH prevalence in T2DMPrevalent NASH cohortNAFLD (NAFL + NASH) prevalence in T2DMTotal prevalent NAFLD (NAFL + NASH) in T2DM
18–34 75,521,000 2.20% 1,661,462 22% 365,522 0.10% 10% 166,146 32.0% 531,668 
35–49 61,419,000 8.10% 4,974,939 35% 1,741,229 0.21% 19% 945,238 54.0% 2,686,467 
50–64 63,302,000 12.40% 7,849,448 47% 3,689,241 0.28% 26% 2,040,856 73.0% 5,730,097 
65+ 49,244,000 20.80% 10,242,752 58% 5,940,796 0.36% 32% 3,277,681 90.0% 9,218,477 
Total 249,486,000 9.91% 24,728,601 47.46% 11,736,787 — 26.0% 6,429,922 73.5% 18,166,709 
Age-group (years)U.S. population sizeDiagnosed T2DMDiagnosed T2DM cohortNAFL prevalence in T2DMPrevalent NAFL cohortAnnual incidence rate of NASH in T2DM with NAFLNASH prevalence in T2DMPrevalent NASH cohortNAFLD (NAFL + NASH) prevalence in T2DMTotal prevalent NAFLD (NAFL + NASH) in T2DM
18–34 75,521,000 2.20% 1,661,462 22% 365,522 0.10% 10% 166,146 32.0% 531,668 
35–49 61,419,000 8.10% 4,974,939 35% 1,741,229 0.21% 19% 945,238 54.0% 2,686,467 
50–64 63,302,000 12.40% 7,849,448 47% 3,689,241 0.28% 26% 2,040,856 73.0% 5,730,097 
65+ 49,244,000 20.80% 10,242,752 58% 5,940,796 0.36% 32% 3,277,681 90.0% 9,218,477 
Total 249,486,000 9.91% 24,728,601 47.46% 11,736,787 — 26.0% 6,429,922 73.5% 18,166,709 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept